What are the limitations of conventional treatment for primary bone cancer and spinal metastasis? How can proton therapy be particularly beneficial for treating primary bone tumors, which are found more often in pediatric patients? And what role can proton therapy play for patients with spinal metastasis? Dr. Michelle Alonso-Basanta, the Helene Blum Assistant Professor in the department of radiation oncology at Penn Medicine, discusses some of the advantages of proton therapy, including precise targeting and reduced toxicity. Dr. Lee Freedman hosts.
